| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0029 | 1 |